ZFGN Zafgen Inc.

4.52
+0.05  (+1%)
Previous Close 4.47
Open 4.45
Price To Book 1.6
Market Cap 166655926
Shares 36,870,780
Volume 68,162
Short Ratio
Av. Daily Volume 274,662

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 data from second cohort released January 17, 2019.
ZGN-1061
Diabetes
Announced July 2016 suspension of development of Beloranib
Beloranib
Severe obesity
Announced July 2016 suspension of development of Beloranib
Beloranib
Prader-Willi Syndrome (PWS)
Announced July 2016 suspension of development of Beloranib
Beloranib
Severe obesity